(Q42269932)

19 October 2017

title

AS03-adjuvanted influenza vaccine in elderly people (English)

1 reference

19 October 2017

1 reference

1

Julie E Ledgerwood

1 reference

19 October 2017

publication date

19 March 2013

1 reference

Lancet Infectious Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

13

1 reference

19 October 2017

issue

6

1 reference

19 October 2017

page(s)

466-467

1 reference

Immunosenescence: role and measurement in influenza vaccine response among the elderly

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970038-0

7 January 2021

10.1016/S1473-3099(13)70038-0

Identifiers

DOI

1 reference

19 October 2017

1 reference